Beta Bionics Ratios (2023-2026) | BBNX

Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 55.68%53.73%53.36%57.19%50.86%53.80%55.48%58.98%59.50%
EBT Margin (Quarter) -64.29%-71.72%-60.77%-59.13%-91.88%-72.58%-52.14%-41.92%-79.26%
EBIT Margin (Quarter) -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%-50.20%-87.86%
EBITDA Margin (Quarter) -97.28%-96.30%-57.81%-88.56%-161.47%-72.98%-51.39%-41.77%-81.06%
Operating Margin (Quarter) -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%-50.20%-87.86%
Net Margin (Quarter) -64.29%-71.72%-60.77%-59.13%-91.88%-72.58%-52.14%-41.92%-79.26%
FCF Margin (Quarter) -97.04%-84.99%-68.79%-72.60%-115.13%-57.50%-31.80%-43.23%-91.25%
Efficiency
Inventory Average (Quarter) 14.53M16.53M18.85M21.05M22.72M
Assets Average (Quarter) 243.83M334.00M330.01M329.39M316.58M
Equity Average (Quarter) -208.71M-217.77M-225.03M-237.10M34.20M307.69M298.20M291.19M279.43M
Invested Capital (Quarter) -203.10M-214.32M-221.21M-228.85M-245.36M313.75M301.63M294.76M287.61M271.25M
Asset Utilization Ratio (Quarter) 0.290.230.270.300.35
Leverage & Solvency
Equity Ratio (Quarter) -1.85-1.640.930.910.890.870.89
Valuation
Enterprise Value (Quarter) -96.75M-22.07M-13.03M-17.48M-103.58M-231.47M-249.72M-228.69M-219.12M-30.31M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%
Return on Capital Employed (Quarter) -23.95%-19.88%-22.52%-24.02%-26.35%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%-0.01%0.00%0.00%0.00%0.00%